Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.

Alterations in p53 and Rb pathways are observed frequently in epithelial ovarian cancer (EOC).However, their roles in EOC initiation remain uncertain. Using a single intrabursal administration of recombinant adenovirus expressing Cre, we demonstrate that concurrent inactivation of p53 and Rb1 is sufficient for reproducible induction of ovarian epithelial carcinogenesis in mice homozygous for conditional gene alleles. Similarly to progression of disease in women, ovarian neoplasms spread i.p., forming ascites, and metastasize to the contralateral ovary, the lung, and the liver. These results establish critical interactions between p53 and Rb1 pathways in EOC pathogenesis, and provide a genetically defined immunocompetent mouse model of sporadic EOC.

[1]  A. Terano,et al.  Incidence of P53 and K‐ras alterations in ovarian mucinous and serous tumors , 2000, Pathology international.

[2]  W. Hahn,et al.  Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.

[3]  Barbara C Vanderhyden,et al.  Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. , 2003, Cancer research.

[4]  T. Inoue,et al.  Combined analysis of p53 and RB pathways in epithelial ovarian cancer. , 2001, Human pathology.

[5]  W. Lee,et al.  Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice. , 1996, Genes & development.

[6]  A. McMahon,et al.  Fate of the mammalian cardiac neural crest. , 2000, Development.

[7]  S. Selvaggi,et al.  Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament , 2009, Archives of pathology & laboratory medicine.

[8]  F. McCormick,et al.  The RB and p53 pathways in cancer. , 2002, Cancer cell.

[9]  P. Briand,et al.  Application of LacZ gene fusions to postimplantation development. , 1993 .

[10]  T. Jacks,et al.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.

[11]  Y. Bignon,et al.  Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). , 2000, International journal of oncology.

[12]  C. Harris,et al.  Oncogenes and tumor-suppressor genes. , 1991, Environmental health perspectives.

[13]  J. Harleman,et al.  Female Genital System , 2001 .

[14]  U. Mohr,et al.  International Classification of Rodent Tumors. The Mouse , 2001, Springer Berlin Heidelberg.

[15]  C. Deng,et al.  Roles of BRCA1 and its interacting proteins , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[16]  M. Wells,et al.  Precursor lesions of ovarian epithelial malignancy , 2001, Histopathology.

[17]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[18]  Haibin Xia,et al.  A simple method for the rapid generation of recombinant adenovirus vectors , 2000, Gene Therapy.

[19]  A. Berns,et al.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.

[20]  A. Villanueva,et al.  K‐ras mutations in mucinous ovarian tumors , 1997, Cancer.

[21]  A. McMahon,et al.  Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. , 2000, Development.

[22]  X. Matías-Guiu,et al.  Loss of Heterozygosity at the RB-1 Locus and pRB Immunostaining in Epithelial Ovarian Tumors: A Molecular, Immunohistochemical, and Clinicopathologic Study , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[23]  A. Fire.  Histochemical techniques for locating Escherichia coli beta-galactosidase activity in transgenic organisms. , 1992, Genetic analysis, techniques and applications.

[24]  A. Nikitin,et al.  Pathology of Ovarian Neoplasms in Genetically Modified Mice. , 2004, Comparative medicine.

[25]  M. Rudnicki,et al.  Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Berns,et al.  Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. , 2000, Genes & development.

[27]  C. Bonnerot,et al.  Application of LacZ gene fusions to postimplantation development. , 1993, Methods in enzymology.

[28]  Chia-Yang Liu,et al.  Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice. , 2002, Cancer research.

[29]  G. Nolan,et al.  Use of Escherichiu coli (E. coli) lacZ (β-Galactosidase) as a Reporter Gene. , 1991, Methods in molecular biology.

[30]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[31]  H. Varmus,et al.  Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. , 2002, Cancer cell.